SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-028795
Filing Date
2024-03-08
Accepted
2024-03-08 17:31:41
Documents
2
Period of Report
2024-03-07

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 16031
2 EX-24.EX24 xene-ex24_ex24.htm EX-24.EX24 9514
  Complete submission text file 0000950170-24-028795.txt   26978
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Issuer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O XENON PHARMACEUTICALS INC. 200 - 3650 GILMORE WAY BURNABY A1 V5G4W8
Business Address
ROBIN SHERRINGTON (Reporting) CIK: 0001619962 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36687 | Film No.: 24735746